EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta …
… with EGFR wild type NSCLC and multiple brain metastases [15]. Considering that EGFR
TKIs are most active in EGFR mutant NSCLC, it is possible that the synergistic effect between …
TKIs are most active in EGFR mutant NSCLC, it is possible that the synergistic effect between …
[HTML][HTML] EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases
K Dong, W Liang, S Zhao, M Guo, Q He… - Translational Lung …, 2019 - ncbi.nlm.nih.gov
… metastasis (BM) in EGFR mutated NSCLC patients. However, whether the combination of
EGFR-TKIs and brain RT is better than EGFR-TKIs … of adding brain RT to EGFR-TKIs and to …
EGFR-TKIs and brain RT is better than EGFR-TKIs … of adding brain RT to EGFR-TKIs and to …
Optimal sequence of local and EGFR-TKI therapy for EGFR-mutant non-small cell lung cancer with brain metastases stratified by number of brain metastases
E Miyawaki, H Kenmotsu, K Mori, H Harada… - International Journal of …, 2019 - Elsevier
… brain metastases and upfront epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)…
patients treated with upfront local therapy for brain metastases and upfront EGFR-TKI. …
patients treated with upfront local therapy for brain metastases and upfront EGFR-TKI. …
EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data
Y Fan, X Xu, C Xie - OncoTargets and therapy, 2014 - Taylor & Francis
… metastases remains controversial. Thus, we performed a pooled analysis of published …
EGFR-TKIs in NSCLC patients with brain metastases, particularly for tumors with activating EGFR …
EGFR-TKIs in NSCLC patients with brain metastases, particularly for tumors with activating EGFR …
The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
H Bai, B Han - OncoTargets and therapy, 2017 - Taylor & Francis
… of EGFR-TKI in brain metastases from NSCLC in recent years. Nonetheless, brain metastases
were … clinical studies involving EGFR-TKI and accounts of its use in intracranial lesions are …
were … clinical studies involving EGFR-TKI and accounts of its use in intracranial lesions are …
Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC
BX Wang, W Ou, XY Mao, Z Liu, HQ Wu… - Clinical Neurology and …, 2017 - Elsevier
… on the incidence of brain metastases has been explored in several … EGFR mutation or
EGFR-TKI use and brain metastases remains to be determined since the sample size of EGFR …
EGFR-TKI use and brain metastases remains to be determined since the sample size of EGFR …
[PDF][PDF] Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated NSCLC patients who develop brain metastasis
W Wang, Z Song, Y Zhang - Archives of Medical Science, 2018 - termedia.pl
… Also, EGFR mutation positive patients with BM tend to do significantly better as compared to
… type EGFR, when treated with EGFR tyrosine kinase inhibitors (TKIs) and brain irradiation […
… type EGFR, when treated with EGFR tyrosine kinase inhibitors (TKIs) and brain irradiation […
Radiotherapy plus EGFR TKIs in non‐small cell lung cancer patients with brain metastases: an update meta‐analysis
T Jiang, W Min, Y Li, Z Yue, C Wu, C Zhou - Cancer Medicine, 2016 - Wiley Online Library
… , which would increase the cerebral concentration of TKIs, we performed … EGFR TKI and
WBRT 14. WBRT could increase the penetration of EGFR TKI via disturbing BBB and EGFR TKI …
WBRT 14. WBRT could increase the penetration of EGFR TKI via disturbing BBB and EGFR TKI …
[HTML][HTML] Brain metastases in EGFR-and ALK-positive NSCLC: outcomes of central nervous system-penetrant tyrosine kinase inhibitors alone versus in combination …
… metastases.19, 20, 21 Nevertheless, in a large, retrospective study of patients with EGFR-…
shorter in patients receiving EGFR TKI therapy alone versus TKI therapy plus upfront WBRT …
shorter in patients receiving EGFR TKI therapy alone versus TKI therapy plus upfront WBRT …
Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches
… EGFR (8%) or WT (4%) EGFR TKI use was associated with … patients with brain metastases
harboring either EGFR and … was found with regards to intracranial PFS. The results of our …
harboring either EGFR and … was found with regards to intracranial PFS. The results of our …
相关搜索
- egfr tki brain radiotherapy
- cell lung cancer brain metastases
- meta analysis brain metastases
- egfr mutation brain metastases
- growth factor receptor brain metastases
- nsclc patients brain metastases
- prognostic factors brain metastases
- targeted therapy brain metastases
- published data brain metastases
- radiation therapy brain metastases
- tyrosine kinase inhibitors brain metastases
- stereotactic radiosurgery brain metastases
- systematic review brain metastases
- tki alone brain metastases
- efficacy and safety brain metastases
- egfr tki non-small cell lung cancer